Other Topics
Kidney Function Tests (KFTs), also known as Renal Function Tests (RFTs), are essential tools for assessing the health and performance of the kidneys. These remarkable organs filter 180 liters of blood daily, regulate fluid and electrolyte balance, maintain acid-base homeostasis, produce hormones, and excrete waste products. KFTs evaluate three critical aspects: glomerular filtration rate (filtration capacity), tubular function (reabsorption and secretion), and urinary findings (urinalysis). Understanding KFT interpretation is crucial for diagnosing kidney disease, monitoring progression, and guiding treatment decisions in conditions ranging from acute kidney injury to chronic kidney disease.
๐ญ The Kidney: Anatomy of a Filtration Powerhouse
The kidneys are sophisticated filtration systems with complex microscopic architecture. Each kidney contains approximately 1 million nephrons, the functional units that perform blood purification. Understanding renal anatomy and physiology is essential for interpreting KFTs accurately:
๐งฌ Nephron Anatomy & Function
- Glomerulus: Tuft of capillaries where filtration occurs
- Bowman's Capsule: Collects the glomerular filtrate
- Proximal Convoluted Tubule (PCT): Reabsorbs 65% of filtrate (glucose, amino acids, electrolytes)
- Loop of Henle: Creates osmotic gradient for urine concentration
- Distal Convoluted Tubule (DCT): Fine-tunes electrolyte balance (regulated by aldosterone)
- Collecting Duct: Final urine concentration (regulated by ADH)
- Key Point: Different tests assess different nephron segments
โ๏ธ Major Kidney Functions
- Filtration (Glomerular):
- GFR: 90-120 mL/min/1.73mยฒ
- Filters small molecules (<68 kDa)
- Excludes cells and large proteins
- Reabsorption & Secretion (Tubular):
- Reabsorbs 99% of filtrate
- Secretes drugs, toxins, H+, K+
- Regulated by hormones (aldosterone, ADH, PTH)
- Endocrine Functions:
- Erythropoietin (RBC production)
- Renin (blood pressure regulation)
- Vitamin D activation (calcium homeostasis)
- Homeostatic Functions:
- Fluid balance (osmoregulation)
- Electrolyte balance (Na+, K+, Ca2+, PO4-)
- Acid-base balance (HCO3- reabsorption, H+ secretion)
๐ฌ The KFT Panel: What's Measured
- Glomerular Function Tests:
- Creatinine (serum)
- Blood Urea Nitrogen (BUN)
- eGFR (estimated GFR)
- Cystatin C
- Tubular Function Tests:
- Urinalysis (specific gravity, pH, glucose)
- Electrolytes (Na+, K+, Cl-, HCO3-)
- Fractional excretion calculations
- Urine osmolality
- Urinalysis Components:
- Dipstick (pH, protein, blood, glucose, ketones)
- Microscopy (cells, casts, crystals)
- Culture (if infection suspected)
- Other Important Tests:
- Serum electrolytes
- Acid-base status (ABG, venous bicarbonate)
- Urine protein quantification
๐ฏ Clinical Memory Aid: Remember the three KFT compartments:
- Glomerular: Creatinine, BUN, eGFR (filtration assessment)
- Tubular: Urine electrolytes, osmolality, fractional excretions (function assessment)
- Urinary Sediment: Cells, casts, crystals (pathology localization)
๐ฌ Glomerular Function Markers: Creatinine & BUN
Creatinine and Blood Urea Nitrogen (BUN) are the primary markers for assessing glomerular filtration rate (GFR). Understanding their metabolism, limitations, and interpretation is fundamental to renal assessment:
๐ Serum Creatinine
- Origin: Muscle metabolism (creatine phosphate breakdown)
- Production: Constant rate (~1-2% of muscle creatine daily)
- Excretion: Almost entirely by glomerular filtration (minimal tubular secretion)
- Normal Range: 0.6-1.2 mg/dL (53-106 ฮผmol/L)
- Limitations:
- Not elevated until GFR decreases by ~50% (insensitive early marker)
- Affected by muscle mass (low in elderly, amputees; high in athletes)
- Affected by diet (meat consumption increases production)
- Drugs can interfere with tubular secretion (trimethoprim, cimetidine)
- Lab assay variations (Jaffe vs enzymatic methods)
- Clinical Interpretation:
- Doubling of creatinine = ~50% reduction in GFR
- Small changes significant: 0.3 mg/dL increase may indicate AKI
- Trend more important than single value
- Key Point: Late marker of renal dysfunction; normal creatinine doesn't exclude early kidney disease
๐ Blood Urea Nitrogen (BUN)
- Origin: Hepatic urea cycle (protein metabolism end product)
- Production: Variable (depends on protein intake, catabolism, liver function)
- Excretion: Glomerular filtration + tubular reabsorption (40-60%)
- Normal Range: 7-20 mg/dL (2.5-7.1 mmol/L)
- Factors Affecting BUN:
- Increased production: High protein diet, GI bleeding, catabolic states, steroids
- Decreased production: Liver disease, malnutrition, low protein diet
- Increased reabsorption: Volume depletion, heart failure, renal hypoperfusion
- Decreased excretion: Renal failure, urinary obstruction
- BUN:Creatinine Ratio:
- Normal: 10:1 to 20:1
- >20:1: Suggests pre-renal azotemia, GI bleeding, catabolic state, obstruction
- <10:1: Suggests liver disease, malnutrition, SIADH, rhabdomyolysis
- Limitation: Many confounding factors limit specificity
- Clinical Pearl: BUN is less reliable than creatinine for GFR estimation but useful for differentiating causes of renal impairment
| Condition | Creatinine Pattern | BUN Pattern | BUN:Creat Ratio | Urine Findings |
|---|---|---|---|---|
| Pre-renal Azotemia | โ (mild-mod) | โโ (disproportionate) | >20:1 | High specific gravity, bland sediment, FENa <1% |
| Acute Tubular Necrosis | โโ | โ | 10-20:1 | Muddy brown casts, granular casts, FENa >2% |
| Glomerulonephritis | โโ | โ | 10-20:1 | Dysmorphic RBCs, RBC casts, proteinuria |
| Urinary Obstruction | โโ | โโ | Variable (>20:1 early) | Variable, may see crystals |
| Liver Disease | Normal/โ | โ/Normal | <10:1 | Normal |
| Rhabdomyolysis | โโโ (early, rapid) | โ | <10:1 | Positive blood, pigmented granular casts |
๐ฌ Clinical Insight: Creatinine is a late and insensitive marker of renal dysfunction. GFR must decrease by approximately 50% before serum creatinine rises above the upper limit of normal. This is due to renal functional reserve and compensatory hyperfiltration in remaining nephrons. Therefore, a "normal" creatinine in an elderly patient with reduced muscle mass may actually represent significantly impaired renal function. Always estimate GFR rather than relying solely on serum creatinine.
๐ Estimated Glomerular Filtration Rate (eGFR)
eGFR is a calculated estimate of actual glomerular filtration rate, providing a more accurate assessment of renal function than serum creatinine alone. Several formulas exist, each with specific applications and limitations:
Creatinine-Based eGFR Formulas
- Cockcroft-Gault Formula (1976): eGFR (mL/min) = [(140 - age) ร weight (kg) ร (0.85 if female)] รท [72 ร Scr (mg/dL)]. Estimates creatinine clearance, not GFR. Limitations: Overestimates in obesity, inaccurate in extremes of age/weight.
- MDRD Study Equation (1999): eGFR = 175 ร (Scr)^{-1.154} ร (age)^{-0.203} ร (0.742 if female) ร (1.212 if African American). More accurate than Cockcroft-Gault, especially at GFR <60 mL/min. Limitations: Less accurate at GFR >60, not validated in children/pregnancy.
- CKD-EPI Equation (2009): Current standard. More accurate at GFR >60, especially in early CKD. Similar variables to MDRD but different coefficients. Recommended by KDIGO guidelines for CKD staging.
- Bedside Schwartz Formula (Pediatric): eGFR (mL/min/1.73mยฒ) = 0.413 ร (height in cm รท Scr in mg/dL). Used for children 1-18 years. Different coefficients for infants.
Cystatin C - The Alternative Marker
- Origin: Produced by all nucleated cells at constant rate
- Advantages over creatinine:
- Less affected by muscle mass, age, gender, race
- Earlier detection of mild GFR reduction
- Better predictor of cardiovascular risk and mortality
- Useful when creatinine unreliable (elderly, amputees, cirrhosis)
- Limitations:
- Affected by thyroid disease, glucocorticoids, inflammation
- More expensive, less widely available
- Less validation in specific populations
- CKD-EPI Cystatin C Equation: Based on cystatin C alone or combined with creatinine
- Clinical Use: When creatinine-based eGFR unreliable, for early CKD detection, risk stratification
๐ฅ CKD Staging by eGFR
| CKD Stage | eGFR (mL/min/1.73mยฒ) | Description | Clinical Implications |
|---|---|---|---|
| G1 | โฅ90 | Normal or high GFR with kidney damage* | Monitor, address risk factors, treat underlying cause |
| G2 | 60-89 | Mildly decreased GFR with kidney damage* | Estimate progression risk, cardiovascular risk assessment |
| G3a | 45-59 | Mildly to moderately decreased GFR | Monitor complications, drug dose adjustments, evaluate for anemia |
| G3b | 30-44 | Moderately to severely decreased GFR | More frequent monitoring, prepare for renal replacement therapy |
| G4 | 15-29 | Severely decreased GFR | Nephrology referral, dialysis access planning, transplant evaluation |
| G5 | <15 | Kidney failure | Dialysis or transplant required |
| *Kidney damage defined as albuminuria (ACR โฅ30 mg/g), abnormal urine sediment, imaging abnormalities, or biopsy-proven damage | |||
โ๏ธ When to Use Which eGFR Formula:
- CKD-EPI: First-line for most adults, especially for CKD staging
- MDRD: Acceptable alternative, slightly less accurate at higher GFR
- Cockcroft-Gault: Primarily for drug dosing (some drugs still use this)
- Cystatin C-based: When creatinine unreliable, for early detection, risk stratification
- Schwartz: For children (age-specific formulas for infants)
- 24-hour creatinine clearance: When accurate GFR needed (pregnancy, extreme body size, renal transplant evaluation)
๐ง Tubular Function Assessment
Tubular function tests evaluate the kidney's ability to reabsorb and secrete substances, maintain concentration gradients, and regulate acid-base and electrolyte balance:
Urine Electrolytes & Fractional Excretions
- Fractional Excretion of Sodium (FENa):
- Formula: (Urine Na ร Plasma Cr) รท (Plasma Na ร Urine Cr) ร 100
- Interpretation:
- <1%: Pre-renal azotemia (intact tubular function)
- >2%: Intrinsic renal failure (ATN, usually)
- 1-2%: Indeterminate
- Limitations: Invalid with diuretics, chronic kidney disease, contrast, urinary obstruction
- Fractional Excretion of Urea (FEUrea):
- Useful when FENa invalid (diuretic use)
- <35% suggests pre-renal azotemia
- >50% suggests intrinsic renal failure
- Urine Sodium Concentration:
- <20 mEq/L: Volume depletion, pre-renal state
- >40 mEq/L: Appropriate renal sodium wasting, ATN
- 20-40 mEq/L: Indeterminate
- Clinical Pearl: FENa is most useful in oliguric AKI; less reliable in non-oliguric AKI or CKD
Urine Concentration & Dilution Tests
- Specific Gravity:
- Normal: 1.003-1.030
- High (>1.020): Concentrated urine (dehydration, pre-renal)
- Low (<1.010): Dilute urine (polydipsia, diabetes insipidus, ATN)
- Fixed (~1.010): Isosthenuria - loss of concentrating ability (advanced CKD, ATN)
- Urine Osmolality:
- More accurate than specific gravity
- Normal: 50-1200 mOsm/kg (depends on hydration)
- Concentrated urine: >500 mOsm/kg
- Dilute urine: <300 mOsm/kg
- Plasma:urine osmolality ratio >1.3 suggests pre-renal
- Water Deprivation Test: Evaluates ADH function and renal concentrating ability
- Clinical Pearl: In pre-renal azotemia, urine should be concentrated (osmolality >500, specific gravity >1.020)
Acid-Base Regulation Tests
- Urine Anion Gap (UAG):
- Formula: Urine (Na + K - Cl)
- Interpretation:
- Positive: Impaired ammonium excretion (renal tubular acidosis type 1, 4)
- Negative: Normal ammonium excretion (GI loss of HCO3-)
- Urine pH:
- Normal range: 4.5-8.0
- Acidic urine (<5.5): Normal response to acidosis
- Alkaline urine (>6.5) in metabolic acidosis: Renal tubular acidosis
- Early morning urine pH most reliable
- Net Acid Excretion: Comprehensive assessment of renal acid handling
- Tubular Maximum for Bicarbonate (TmHCO3): Assesses proximal tubular HCO3- reabsorption
Proximal Tubular Function Tests
- Urine Glucose:
- Normal: Negative (renal threshold ~180 mg/dL)
- Glycosuria with normal blood glucose: Renal glycosuria (SGLT2 defect)
- Urine Amino Acids: Aminoaciduria in Fanconi syndrome
- Urine Phosphate:
- Fractional excretion of phosphate (FEPO4)
- Increased in hyperparathyroidism, Fanconi syndrome
- Urine Uric Acid:
- Fractional excretion of uric acid (FEUA)
- Increased in proximal tubular disorders
- Clinical Pearl: Generalized proximal tubular dysfunction = Fanconi syndrome (glycosuria, aminoaciduria, phosphaturia, bicarbonaturia)
| Disorder | Primary Defect | Key Laboratory Findings | Clinical Features |
|---|---|---|---|
| Proximal RTA (Type 2) | Impaired HCO3- reabsorption | Normal anion gap metabolic acidosis, urine pH <5.5 if plasma HCO3- low, FEHCO3 >15% when infused | Growth retardation in children, osteomalacia, nephrolithiasis |
| Distal RTA (Type 1) | Impaired H+ secretion | Normal anion gap metabolic acidosis, urine pH >5.5, positive urine anion gap, hypokalemia | Nephrolithiasis, nephrocalcinosis, bone disease |
| Type 4 RTA | Aldosterone deficiency/resistance | Hyperkalemia, metabolic acidosis, urine pH <5.5, low aldosterone/renin | Diabetes, CKD, medication-induced (ACEi, NSAIDs, heparin) |
| Fanconi Syndrome | Generalized proximal tubular dysfunction | Glycosuria, aminoaciduria, phosphaturia, bicarbonaturia, uricosuria | Rickets/osteomalacia, growth failure, polyuria, polydipsia |
| Nephrogenic DI | ADH resistance | Polyuria, urine osmolality <300 despite dehydration, normal/increased ADH | Polyuria, polydipsia, hypernatremia if water unavailable |
๐ Urinalysis: The Window to Kidney Health
Urinalysis provides invaluable information about kidney health, comprising dipstick chemical analysis and microscopic examination of sediment. It's often the first test to suggest renal disease:
Dipstick Chemical Analysis
- Protein: Trace: <30 mg/dL, 1+: 30 mg/dL, 2+: 100 mg/dL, 3+: 300 mg/dL, 4+: >1000 mg/dL. False positives: Highly alkaline urine, contamination, hematuria, radiocontrast. Always confirm with quantitative measurement (spot protein:creatinine ratio or 24-hour collection).
- Blood: Detects hemoglobin/myoglobin (RBC lysis). 1-3 RBCs/HPF usually positive. False positives: Menstrual contamination, strenuous exercise. False negatives: Ascorbic acid, captopril, high specific gravity.
- Glucose: Positive when blood glucose >180 mg/dL (renal threshold). Renal glycosuria: Positive dipstick with normal blood glucose (SGLT2 defect).
- Ketones: Acetoacetate and acetone (not ฮฒ-hydroxybutyrate). Positive in DKA, starvation, alcoholic ketoacidosis, high-fat diet.
- Bilirubin/Urobilinogen: Bilirubin: Conjugated only (water-soluble). Urobilinogen: Normal <1 mg/dL. Increased in liver disease, hemolysis.
- Nitrites/Leukocyte Esterase: Nitrites: Gram-negative bacteria convert nitrates โ nitrites. Leukocyte esterase: Enzyme from neutrophils. Both positive suggests UTI.
Microscopic Urine Sediment
- Red Blood Cells (RBCs): Normal: 0-3/HPF. >5/HPF = microscopic hematuria. Isomorphic: Uniform shape (lower tract origin). Dysmorphic: Irregular shape with blebs (glomerular origin).
- White Blood Cells (WBCs): Normal: 0-5/HPF. >10/HPF = pyuria. Indicates inflammation/infection. WBC casts: Tubulointerstitial inflammation (pyelonephritis, interstitial nephritis).
- Casts: Hyaline casts: Concentrated urine, normal. Granular casts: Degenerated cellular casts, ATN. RBC casts: Glomerulonephritis (pathognomonic). WBC casts: Pyelonephritis, interstitial nephritis. Fatty casts: Nephrotic syndrome. Waxy casts: Advanced renal disease.
- Crystals: Calcium oxalate: Envelope-shaped (ethylene glycol poisoning, hyperoxaluria). Uric acid: Rhomboid/rosette (gout, tumor lysis). Triple phosphate (struvite): Coffin-lid (UTI with urea-splitting organisms). Cystine: Hexagonal (cystinuria).
- Other Elements: Epithelial cells: Squamous (contamination), renal tubular (ATN). Bacteria: >20/HPF suggests infection. Yeast: Candida species (diabetes, immunocompromised).
๐ฌ Urinary Sediment Patterns in Renal Diseases
| Condition | Dipstick Findings | Microscopic Findings | Clinical Correlation |
|---|---|---|---|
| Acute Glomerulonephritis | Protein 1-3+, Blood 2-4+ | Dysmorphic RBCs, RBC casts, lipiduria | Nephritic syndrome (hematuria, proteinuria, hypertension, renal impairment) |
| Nephrotic Syndrome | Protein 3-4+, Blood ยฑ | Fatty casts, oval fat bodies, lipiduria ("Maltese crosses") | Heavy proteinuria (>3.5 g/d), hypoalbuminemia, edema, hyperlipidemia |
| Acute Tubular Necrosis | Protein ยฑ, Blood ยฑ | Muddy brown granular casts, renal tubular epithelial cells, epithelial casts | Ischemic or toxic injury, FENa >2%, urine osmolality ~300 |
| Acute Interstitial Nephritis | Protein 1-2+, Blood ยฑ | WBC casts, eosinophils (Hansel's stain), WBCs | Drug-induced (NSAIDs, antibiotics), fever, rash, eosinophilia |
| Urinary Tract Infection | Nitrites +, Leuk esterase +, Blood ยฑ | WBCs, bacteria (>20/HPF), possible WBC casts if pyelonephritis | Dysuria, frequency, fever (if pyelonephritis) |
| Pre-renal Azotemia | Normal or concentrated | Bland sediment, hyaline casts | Volume depletion, heart failure, FENa <1%, high urine osmolality |
๐ Clinical Pearl: RBC casts are pathognomonic for glomerulonephritis. Their presence indicates glomerular inflammation and should prompt urgent nephrology referral. Conversely, the absence of RBC casts does not exclude glomerulonephritis, as they may be intermittent or not present in all cases. Always look carefully for casts by examining the edges of the coverslip under low light.
โ ๏ธ Acute Kidney Injury (AKI) Assessment
AKI is a rapid decline in kidney function, diagnosed and staged using standardized criteria. Prompt recognition and differentiation of causes are crucial for management:
๐จ KDIGO AKI Diagnostic Criteria:
- Stage 1: โ Creatinine 1.5-1.9ร baseline OR โ โฅ0.3 mg/dL (โฅ26.5 ฮผmol/L) OR urine output <0.5 mL/kg/h for 6-12h
- Stage 2: โ Creatinine 2.0-2.9ร baseline OR urine output <0.5 mL/kg/h for โฅ12h
- Stage 3: โ Creatinine 3.0ร baseline OR โ โฅ4.0 mg/dL (โฅ353.6 ฮผmol/L) OR initiation of renal replacement therapy OR urine output <0.3 mL/kg/h for โฅ24h OR anuria for โฅ12h
- Key Points:
- Use the highest stage reached by either creatinine or urine output criteria
- 48-hour window for diagnosis
- Baseline creatinine is ideally known; if not, assume normal GFR if no CKD history
๐ Differential Diagnosis of AKI
Pre-renal AKI (55%)
- Pathophysiology: Renal hypoperfusion
- Causes:
- Volume depletion (dehydration, hemorrhage, GI losses)
- Cardiac failure (cardiogenic shock, tamponade)
- Renal vasoconstriction (NSAIDs, ACEi, hepatorenal syndrome)
- Systemic vasodilation (sepsis, anaphylaxis)
- Laboratory Findings:
- BUN:Cr >20:1
- FENa <1% (except with diuretics, CKD, contrast)
- Urine osmolality >500 mOsm/kg
- Urine Na <20 mEq/L
- Bland urinary sediment
- Treatment: Restore perfusion (fluids, treat underlying cause)
Intrinsic Renal AKI (40%)
- Categories:
- Glomerular: Glomerulonephritis, vasculitis
- Tubular: ATN (ischemic, toxic)
- Interstitial: Acute interstitial nephritis (drugs, infection)
- Vascular: Thrombotic microangiopathy, renal artery/vein thrombosis
- Laboratory Findings:
- BUN:Cr 10-20:1
- FENa >2% (except in glomerular disease)
- Urine osmolality ~300 mOsm/kg (isosthenuria)
- Urine Na >40 mEq/L
- Active urinary sediment (casts, cells)
- Treatment: Specific to cause (steroids for GN, stop offending drug for AIN)
Post-renal AKI (5%)
- Pathophysiology: Urinary outflow obstruction
- Causes:
- Prostatic hypertrophy/cancer
- Ureteral obstruction (stones, tumors, fibrosis)
- Bladder outlet obstruction
- Retroperitoneal fibrosis
- Laboratory Findings:
- Early: BUN:Cr >20:1 (like pre-renal)
- Late: BUN:Cr 10-20:1
- FENa variable
- Urinalysis may show crystals, hematuria
- Diagnosis: Ultrasound (hydronephrosis)
- Treatment: Relief of obstruction (catheter, stent, nephrostomy)
๐ Novel AKI Biomarkers:
- TIMP-2 ร IGFBP7 (NephroCheckยฎ): Urinary cell cycle arrest biomarkers predict moderate-severe AKI within 12h
- NGAL (Neutrophil Gelatinase-Associated Lipocalin): Urinary/serum marker rises 2-4h after injury
- KIM-1 (Kidney Injury Molecule-1): Urinary marker of proximal tubular injury
- IL-18 (Interleukin-18): Urinary marker of acute tubular necrosis
- L-FABP (Liver-type Fatty Acid-Binding Protein): Urinary marker of tubular hypoxia
- Clinical Utility: Early detection before creatinine rise, differential diagnosis, prognosis, monitoring response
๐ Abbreviations & Terminology
Essential abbreviations and terminology for KFT interpretation:
| Abbreviation | Full Name | Definition/Context |
|---|---|---|
| KFTs/RFTs | Kidney/Renal Function Tests | Panel assessing glomerular filtration, tubular function, urinalysis |
| GFR | Glomerular Filtration Rate | Volume of fluid filtered by glomeruli per unit time (mL/min) |
| eGFR | Estimated GFR | Calculated estimate of GFR using creatinine-based formulas |
| BUN | Blood Urea Nitrogen | Measure of urea concentration in blood |
| Cr | Creatinine | Breakdown product of muscle metabolism, primary GFR marker |
| CKD | Chronic Kidney Disease | Kidney damage or GFR <60 mL/min for โฅ3 months |
| AKI | Acute Kidney Injury | Rapid decline in kidney function (hours to days) |
| ATN | Acute Tubular Necrosis | Most common cause of intrinsic AKI |
| AIN | Acute Interstitial Nephritis | Drug-induced renal inflammation |
| FENa | Fractional Excretion of Sodium | Percentage of filtered sodium excreted in urine |
| FEUrea | Fractional Excretion of Urea | Alternative to FENa when diuretics used |
| UAG | Urine Anion Gap | Calculated as (Na + K - Cl), assesses ammonium excretion |
| ACR | Albumin:Creatinine Ratio | Spot urine test to quantify albuminuria |
| PCR | Protein:Creatinine Ratio | Spot urine test to quantify total proteinuria |
| RTA | Renal Tubular Acidosis | Impaired renal acid excretion with normal GFR |
| DI | Diabetes Insipidus | Impaired urine concentration (central or nephrogenic) |
| KDIGO | Kidney Disease: Improving Global Outcomes | International organization developing CKD/AKI guidelines |
| MDRD | Modification of Diet in Renal Disease | Study that developed MDRD eGFR equation |
| CKD-EPI | Chronic Kidney Disease Epidemiology Collaboration | Current standard eGFR equation |
| ESRD | End-Stage Renal Disease | Stage 5 CKD requiring dialysis/transplant |
| RRT | Renal Replacement Therapy | Dialysis or kidney transplantation |
| GN | Glomerulonephritis | Inflammation of glomeruli |
| NS | Nephrotic Syndrome | Heavy proteinuria (>3.5 g/d) with hypoalbuminemia, edema, hyperlipidemia |
| UTI | Urinary Tract Infection | Infection of urinary system |
| HPF | High Power Field | Microscopy term (400ร magnification) |
| SIADH | Syndrome of Inappropriate ADH Secretion | Hyponatremia with inappropriately concentrated urine |
| ADH | Antidiuretic Hormone (Vasopressin) | Regulates water reabsorption in collecting duct |
| SGLT2 | Sodium-Glucose Co-Transporter 2 | Proximal tubular glucose reabsorption protein |
| NGAL | Neutrophil Gelatinase-Associated Lipocalin | Novel AKI biomarker |
| KIM-1 | Kidney Injury Molecule-1 | Novel AKI biomarker |
๐ Memory Aid: Key KFT patterns and values:
- Normal eGFR: โฅ90 mL/min/1.73mยฒ
- Pre-renal AKI: FENa <1%, BUN:Cr >20:1, urine osmolality >500
- Intrinsic AKI: FENa >2%, BUN:Cr 10-20:1, urine osmolality ~300
- Microscopic hematuria: >5 RBCs/HPF
- Pyuria: >10 WBCs/HPF
- Significant proteinuria: ACR โฅ30 mg/g or PCR โฅ150 mg/g
- Nephrotic range proteinuria: >3.5 g/d or PCR >3500 mg/g
- RBC casts: Pathognomonic for glomerulonephritis
๐ฏ Clinical Pearls & Interpretation Framework
Systematic approach to KFT interpretation:
- Step 1: Assess Glomerular Function
- Calculate eGFR using CKD-EPI equation
- Stage CKD if eGFR <60 for โฅ3 months
- Check for AKI using KDIGO criteria if acute rise
- Evaluate BUN:Cr ratio for clues
- Step 2: Perform & Interpret Urinalysis
- Dipstick: Protein, blood, glucose, nitrites, leukocyte esterase
- Microscopy: Cells, casts, crystals
- Quantify proteinuria if dipstick positive (spot ACR/PCR)
- Culture if infection suspected
- Step 3: Evaluate Tubular Function
- Calculate FENa/FEUrea in AKI
- Assess urine concentration (osmolality/specific gravity)
- Check urine electrolytes if electrolyte disorders present
- Evaluate acid-base status if metabolic acidosis
- Step 4: Consider Clinical Context
- Acute vs chronic presentation
- Symptoms: Edema, hematuria, dysuria, flank pain, oliguria
- Risk factors: Diabetes, hypertension, medications, family history
- Physical exam: Blood pressure, volume status, edema
- Step 5: Order Targeted Investigations
- Renal ultrasound: Size, echogenicity, obstruction
- Serologies: ANA, ANCA, anti-GBM, complement levels if GN suspected
- Electrolytes, calcium, phosphate, PTH for mineral bone disease
- Renal biopsy if diagnosis uncertain and management would change
- Step 6: Monitor & Manage
- Adjust drug doses based on eGFR
- Manage complications (anemia, bone disease, acidosis)
- Refer to nephrology if eGFR <30, rapid decline, or complex case
- Prepare for RRT if progressing to ESRD
๐ฌ KFT Interpretation Study Tips:
- Master the three compartments: Glomerular (creatinine/BUN/eGFR), tubular (electrolytes/FENa/osmolality), urinary (dipstick/microscopy)
- Learn the key formulas: FENa, eGFR equations, ACR/PCR calculations
- Know pattern recognition: Pre-renal vs intrinsic vs post-renal AKI
- Understand urinary sediment: RBC casts (GN), WBC casts (pyelonephritis/AIN), granular casts (ATN)
- Recognize emergencies: Rapidly progressive GN, hyperkalemia, uremic pericarditis
- Know common causes: Diabetes and hypertension cause 2/3 of CKD
- Use systematic approach: GFR โ urinalysis โ tubular function โ context โ investigations
- Contextualize: Acute vs chronic, symptomatic vs asymptomatic, risk factors
๐งญ Key Principles of KFT Interpretation
Core concepts for effective KFT interpretation:
- Creatinine Limitations: Late marker, affected by muscle mass, insensitive for early CKD
- Always Calculate eGFR: More accurate than creatinine alone, essential for CKD staging
- Trend Over Single Value: Rate of change often more informative than absolute value
- Urinalysis is Essential: Often the first clue to renal disease type
- Differentiate AKI Causes: Pre-renal, intrinsic, post-renal have different management
- Quantify Proteinuria: Dipstick semi-quantitative; always confirm with ACR/PCR
- Consider Drug Effects: Many drugs affect creatinine, GFR, or cause kidney injury
- Age-Appropriate Normals: GFR declines with age; different expectations for elderly
- Integrated Assessment: Combine labs with clinical context, imaging, sometimes biopsy
- Prevention Focus: Identify and manage risk factors (BP, glucose, proteinuria)
๐ Conclusion
Kidney Function Tests provide a comprehensive assessment of renal health, evaluating the complex interplay of filtration, reabsorption, secretion, and endocrine functions. From the basic serum creatinine to sophisticated eGFR calculations, from simple dipstick urinalysis to detailed microscopic sediment examination, KFTs offer a window into renal physiology and pathology. Mastery of KFT interpretation requires understanding not just what each test measures, but also their limitations, interrelationships, and clinical correlations.
The art of renal assessment lies in pattern recognition: distinguishing pre-renal from intrinsic renal disease, glomerular from tubular disorders, acute from chronic processes. The combination of quantitative blood tests with qualitative urine examination often provides the key to diagnosis. In an era of rising chronic kidney disease prevalence, early detection through proper KFT interpretation can slow progression and prevent complications.
KFTs serve multiple critical roles in clinical practice: screening asymptomatic individuals at risk, diagnosing symptomatic renal disease, monitoring disease progression and treatment response, guiding medication dosing, and determining timing of renal replacement therapy. With advances in novel biomarkers and imaging techniques, renal assessment continues to evolve, but the fundamental principles of KFT interpretation remain essential for all clinicians. Remember: the kidneys speak through their filtration products and urinary sediment; learning to interpret this language enables early intervention that can preserve renal function and improve patient outcomes.
Kidney Function Test interpretation combines biochemical analysis with clinical integration โ recognizing patterns while remembering that renal function exists on a continuum from optimal health to complete failure. The kidneys' silent work is revealed through careful laboratory assessment; understanding these revelations guides interventions that can prevent the progression from injury to irreversible failure.